ÂÜẠ̀ẨÂ×

Jonathan Weissman is the Landon T. Clay professor of Biology at Whitehead Institute for Biomedical Research and the Department of Biology at MIT, and an investigator of the Howard Hughes Medical Institute.

He serves as the co-director of the Innovative Genomics Institute (IGI) of Berkeley and UCSF and on the President’s Advisory Group for the Chan Zuckerberg Biohub. He also is the chairman of the scientific advisory board for the Stowers Institute and serves on the scientific advisory board for Amgen and the Helen Hay Whitney Foundation. Additionally, Jonathan is a co-founder of KSQ therapeutics and Maze therapeutics.

He has received the Ira Herskowitz Award from the Genetic Society of America, Irving Sigal Young Investigator Award from the Protein Society, the Raymond and Beverly Sackler International Prize in Biophysics, the National Academy of Sciences Award for Scientific Discovery, and the Keith R. Porter Lecture Award from the American Society for Cell Biology. Jonathan is a member of the National Academy of Sciences.